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1875-9572/Copyright ª 2015, TaiwanBackground: Bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension (PH) is a
well-known complication of prematurity; however, the additional impact of a left-to-right in-
teratrial shunt on this condition remains poorly understood. The aim of the present study was
to identify the significance of atrial left-to-right shunt lesions in PH infants with moderate or
severe BPD.
Methods: The medical records of 383 preterm infants (gestational age of < 32 weeks) who
were diagnosed with BPD between 2005 and 2013 were retrospectively reviewed. Baseline
characteristics such as interatrial shunts and outcomes were compared between the infants
who developed PH (nZ 50) and infants who did not (nZ 144). Infants with hemodynamically
significant residual patent ductus arteriosus were excluded. Among the infants diagnosed with
PH (n Z 50), the outcomes were compared between the patients with (n Z 21) and without
atrial shunts (n Z 29) at 36 weeks corrected postmenstrual age.
Results: Fifty (15%) preterm infants with BPD were diagnosed with PH. The number of infants
with a history of atrial shunt lesions was significantly higher in the PH group than in the non-PH
group (42% vs. 15.3%, respectively). The adjusted odds ratio for PH in the atrial shunt group
was 3.8 (95% confidence interval, 1.8e8.0), compared to PH-BPD infants without an atrial
shunt.of Pediatrics, Seoul National University Children’s Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-
r (H.-S. Kim).
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Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
318 E.K. Choi et alConclusion: The presence of an atrial left-to-right shunt was associated with PH in preterm in-
fants with moderate or severe BPD. Close follow up is needed for infants with interatrial
shunts, and a more tailored prognostic evaluation and treatment are recommended.
Copyright ª 2015, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Despite advances in critical care management, chronic
pulmonary morbidity is a common adverse outcome in
preterm neonates, particularly in preterm infants who
develop bronchopulmonary dysplasia (BPD).1 Pulmonary
hypertension (PH) is a major cause of late mortality in
preterm infants with BPD.2 Previous retrospective studies
have reported PH-associated mortality rates ranging be-
tween 14% and 38% in preterm infants with BPD. The only
currently published prospective study reports a prevalence
of 18% and a mortality rate of 11.5% for extremely low-
birth-weight infants. Survivors are at an increased risk of
long-term morbidity such as long hospitalizations and oxy-
gen therapy.3e5
The pathogenesis of PH in infants with BPD is multifac-
torial, and infants with BPD may develop PH because of
early damage to pulmonary angiogenesis, which could be
exacerbated by inflammation,6 lung and airway injuries,7
cardiac shunts, diastolic cardiac dysfunction, and pulmo-
nary vein stenosis.8 Previous studies have reported that
infants with PH frequently had a history of minor cardiac
anomalies, and it was suggested that infants with chronic
lung disease (CLD) and shunt lesions may be at an increased
risk for PH.9,10 It maybe that even minor increases in left-
to-right shunting of the blood through atrial defects may
induce a significant hemodynamic injury and aggravate PH
because of the reduced vascular surface area in the lungs of
infants with BPD.11 However, the exact significance of this
minor cardiac anomaly is unknown.12 The present study was
conducted to investigate the clinical impact of atrial left-
to-right shunts on PH prevalence in preterm infants with
severe or moderate BPD.
2. Materials and methods
This study was approved by the Institutional Research
Ethics Committee at Seoul National University Hospital
(Seoul, South Korea).
2.1. Patients and definitions
We retrospectively reviewed themedical records of preterm
infants who were born at < 32 weeks gestational age and
admitted to the neonatal intensive care unit (NICU) at Seoul
National University Children’s Hospital (Seoul, South Korea)
between January 2005 and March 2013. During the study
period, 383 preterm infants were diagnosed as having BPD.
Excluded from the study were infants with major congenital
heart diseases [except for patent ductus arteriosus (PDA)],patent foramen ovale (PFO), and atrial septal defect (ASD)],
chromosomal abnormalities, congenital diaphragmatic her-
nia, and persistent PH. Infants who were transferred to our
hospital after 36 weeks corrected postmenstrual age (PMA)
or who died before 36 weeks PMA were also excluded
(n Z 49).
The clinical data collected included birth weight,
gestational age, prenatal steroids (administration of any
dose of corticosteroids during the concurrent pregnancy),
histological chorioamnionitis (based on the pathological
findings from the microscopic examination of the placenta),
PDA and its treatment, BPD and its grade, and culture-
proven sepsis. Patients with PDA that were treated with
cyclooxygenase inhibitors or surgical ligation and hemody-
namically significant residual PDAs after 36 weeks PMA were
excluded. Bronchopulmonary dysplasia was defined using
the National Institute of Child Health criteria and was
graded as “mild”, “moderate”, or “severe”, according to
the fraction of inspired oxygen (FiO2) or use of positive
pressure ventilation (PPV). “Mild BPD” was defined as
breathing room air; “moderate BPD” was defined as a FiO2
< 0.30, and “severe BPD” was defined as FiO2  0.30 or use
of PPV at 36 weeks PMA. A pediatric cardiologist at Seoul
National University Children’s Hospital reviewed serial
echocardiographic data such as evaluations with two-
dimensional, M-mode, and color-coded Doppler for all
preterm infants with moderate to severe BPD. Infants were
diagnosed with PH if an echocardiogram that was per-
formed when they were older than 2 months demonstrated
elevated pulmonary artery pressure, based on the presence
of at least one of the following criteria: (1) velocity of
tricuspid valve regurgitation (TR)  3 m/s in the absence of
pulmonary stenosis or (2) flat or left-deviated interven-
tricular septal configuration and right ventricular hyper-
trophy with chamber dilation.13,14 Data on the infants’
interatrial shunts at 36 weeks PMA were collected and
followed up using echocardiography. We recorded the final
diagnoses of atrial shunts (ASD or PFO) that remained open
at the corrected postnatal age of 2 months.15
2.2. Statistical analysis
All data analysis was performed using SPSS 20.0 for Win-
dows (SPSS Inc., Chicago, IL, USA). Continuous variables
were analyzed using either the t test or the ManneWhitney
U test for normal or skewed distributions, respectively.
Proportions were tested using the Chi-square test and the
Fisher’s exact test, and p < 0.05 were considered signifi-
cant. The significant variables identified by univariate
analysis were further assessed with multivariable logistic
regression analysis. Data are presented by the mean  the
Atrial LefteRight Shunt and Pulmonary Hypertension 319standard deviation (SD), by the median and range, or by the
rate. Odds ratios are presented with 95% confidence
intervals.
3. Results
3.1. Patients
Of the total 383 preterm infants with BPD who were born at
< 32 weeks gestational age, five infants were excluded
because of death prior to 36 weeks PMA; 29 infants were
excluded because of major congenital malformations; and
15 infants were excluded because of incomplete follow-up
data. The remaining 334 preterm infants with BPD fulfilled
the inclusion criteria. A flow diagram is presented in
Figure 1.
3.2. Pulmonary hypertension with moderate or
severe bronchopulmonary dysplasia
Among the 334 infants with BPD, 50 (15%) were diagnosed
with PH. Pulmonary hypertension was diagnosed in 54% (45/
83) of infants with severe BPD, 4% (5/111) of infants withFigure 1 Flow diagram of the study design. BPD Z bro
PMA Z corrected postmenstrual age.moderate BPD, and 0% (0/140) of infants with mild BPD.
Except for infants with mild BPD, the clinical characteris-
tics and outcomes for infants with (nZ 50) and without PH
(n Z 144) are presented in Table 1. According to the PH
diagnostic criteria, systolic pulmonary artery pressure
could be estimated in 64% (32) of infants by measurable TR.
The median measurable TR in PH infants was 3.4 m/s
(range, 3.0e4.2 m/s). We used the modified Bernoulli
equation to convert the Doppler-derived velocity to pres-
sure [i.e., the pressure gradient between the right ventricle
and right atrium Z 4  (TR max2); median, 46.2 mmHg;
range, 36.0e70.6 mmHg]. For the remaining 36% (18) of the
infants with PH, qualitative echocardiographic measures of
PH in the absence of measureable TR such as septal flat-
tening, right atrial enlargement, right ventricular hyper-
trophy, and right ventricular dilatation were used as
diagnostic tools. Only two infants in the PH group and one
infant in the non-PH group had small residual PDAs at 36
weeks PMA; however, these small residual PDAs were he-
modynamically insignificant and were immediately closed
prior to discharge.
The infants with PH spent more days on a mechanical
ventilator (p < 0.001) such as a high-frequency ventilator
(HFV), but fewer days on nasal continuous positive airwaynchopulmonary dysplasia; PH Z pulmonary hypertension;
Table 1 Univariate analysis of clinical characteristics of infants with and without pulmonary hypertension.
Infants without pulmonary
hypertension
Infants with pulmonary
hypertension
p
N Z 144 N Z 50
Gestational age (wk) 26.6  1.9 26.2  2.0 0.221
Birth weight (g) 825  253 754  227 0.08
Birth weight (<10th percentile for age) 37 (25.5) 15 (30.0) 0.581
Multiple birth 87 (60.4) 18 (36.0) 0.003
Cesarean section 92 (63.9) 33 (66.0) 0.865
Perinatal steroids administration 110 (76.9) 35 (77.8) 1.000
Chorioamnionitis 55 (38.2) 22 (47.8) 0.301
Atrial left-to-right shunt at 36 weeks PMA 22 (15.3) 21 (42.0) <0.001
Morbidity and mortality
RDS 97 (67.4) 36 (72.0) 0.599
Treated PDA with medication or ligation operation 129 (89.6) 48 (96.0) 0.245
BPD
Severe/moderate 38/106 (26.4/73.6) 45/5 (90.0/10.0) <0.001
IVH Grade 3 or 4 27 (18.87) 8 (16.0) 0.831
PVL 14 (9.7) 4 (8.0) 1.000
Culture-proven sepsis 27 (18.8) 23 (46.0) <0.001
ROP operation 55 (38.2) 24 (48.0) 0.245
Death 0 (0) 3 (6.0) 0.016
Length of stay (d) 99.3 (48e214) 112.0 (56e329) 0.04
Respiratory support
Duration of oxygen therapy (d) 86.3 (1.0e214) 104 (48e456) 0.002
Duration of CV or HFV (d) 34.4 (0e123) 69.4 (0e456) <0.001
Duration of nCPAP (d) 11 (0e64) 1.3 (0.0e49) <0.001
Discharged home on oxygen 51 (35.4) 40 (80.0) <0.001
Data are presented by n (%), mean  SD, median and range.
BPD Z bronchopulmonary dysplasia; CV Z conventional ventilation; HFV Z high-frequency ventilation; IVH Z intraventricular hem-
orrhage; nCPAP Z nasal continuous positive airway pressure; NEC Z necrotizing enterocolitis; PDA Z patent ductus arteriosus;
PVL Z periventricular leukomalacia; RDS Z respiratory distress syndrome; ROP Z retinopathy of prematurity.
320 E.K. Choi et alpressure (nCPAP; p < 0.001), compared to infants in the
non-PH group. Three infants in the PH group died during
hospitalization, but there were no deaths in the non-PH
group (p Z 0.016). The causes of death for the three in-
fants were respiratory failure, despite mechanical ventila-
tion and a high fraction of oxygen. The median duration of
hospitalization was longer in the PH group than in the non-
PH group (pZ 0.04). Most infants in the PH group required
prolonged oxygen therapy at discharge, compared to the
non-PH group (80% vs. 35.4%, respectively; p < 0.001).
Multivariate analysis was performed to investigate the
risk factors for PH. The results after adjusting for variables
that were significant in the previous univariate analysis
revealed that the significant risk factors for PH were proven
sepsis (adjusted OR 3.5; 95% CI, 1.7e7.2; p Z 0.001) and
interatrial shunts [adjusted odds ratio (OR) 3.8; 95% CI,
1.8e8.0; p < 0.001] (Table 2).Table 2 Multiple logistic analysis of pulmonary hypertension in
Clinical characteristics Unadjusted OR (
Proven sepsis 3.7 (1.8e7.4)
Atrial left-to-right shunt at 36 weeks PMA 3.5 (1.7e7.0)
CI Z confidence interval; OR Z odds ratio; PMA Z postmenstrual ag3.3. Comparison of PH-BPD infants with and
without atrial left-to-right shunt
We obtained a median 968 days (range, 64e2875 days) of
follow-up data after the diagnosis of PH. The median
postnatal age at the initial diagnosis of PH was 87.5 days
(range, 7e882 days) in the PH group. The median age at the
PH diagnosis in the atrial shunt group was significantly
earlier than the median age in the nonatrial shunt group (62
days vs. 103 days, p Z 0.004).
Major morbidities and outcomes were compared be-
tween infants with (n Z 21) and without atrial shunts
(nZ 29; Table 3). The hospitalization duration (pZ 1.000),
oxygen therapy (p Z 0.567), mechanical ventilation
(p Z 0.589), and nCPAP (p Z 0.252) did not differ signifi-
cantly between the two groups. However, the mortalityinfants with moderate or severe bronchopulmonary dysplasia.
95% CI) p Adjusted OR (95%CI) p
<0.001 3.5 (1.7e7.2) 0.001
<0.001 3.8 (1.8e8.0) <0.001
e.
Table 3 Comparison of clinical outcomes between infants with pulmonary hypertensionebronchopulmonary dysplasia with
and without atrial left-to-right shunts.
PH without atrial left-to-right shunt PH with atrial left-to-right shunt p
N Z 29 N Z 21
Morbidity and mortality
BPD
Severe/moderate 27/2 (93.1/6.9) 18/3 (85.7/14.3) 0.638
Culture-proven sepsis 11 (37.9) 12 (57.1) 0.252
Treated PDA with medication
or ligation operation
27 (93.1) 19 (90.0) 0.993
Death 0 (0) 3 (14.3) 0.026
Length of stay (d) 112.0 (64.0e293.0) 111.0 (56.0e456.0) 1.000
Respiratory support
Duration of O2 therapy (d) 112.0 (65.0e293.0) 102.0 (48.0e456.0) 0.567
Duration of CV or HFV(d) 69.0 (13.0e243.0) 69.7 (0e456.0) 0.810
Duration of nCPAP(d) 20.0 (0e80.0) 6.3 (0e49.0) 0.252
Discharged home on O2 24 (60.0) 16 (40) 0.692
Data are presented by n (%) or median and range.
BPD Z bronchopulmonary dysplasia; CV Z conventional ventilation; HFV Z high-frequency ventilation; nCPAP Z nasal continuous
positive airway pressure; O2 Z oxygen; PDA Z patent ductus arteriosus; PH Z pulmonary hypertension.
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shunts than in PH-BPD infants without atrial shunts (14.3%
vs. 0%, respectively; p Z 0.026). During the follow-up
period, four infants in the atrial shunt group died,
including three infants who died during hospitalization and
one infant who died suddenly at home 2 days after being
discharged without any improvement in PH.
In our hospital, management for PH in BPD infants in-
cludes inhaled nitric oxide (NO), sildenafil, bosentan, and
inhaled iloprost. Eighteen (85.7%) infants in the atrial shunt
group received at least one of these pulmonary vasodilator
therapies during the follow-up period, whereas only 17
(58.6%) infants in the nonatrial shunt group received these
therapies (p Z 0.038). Sildenafil was administered most
often. In each group, the following drugs were adminis-
tered: in the atrial shunt group, inhaled NO [7 (33.3%) in-
fants], sildenafil [17 (81.0%) infants], bosentan [3 (14.2%)
infants], and [iloprost 6 (28.6%) infants]; in the nonatrial
shunt group, inhaled NO [9 (31.0%) infants], sildenafil [16
(55.2%) infants], bosentan [1 (3.4%) infants], and iloprost [1
(3.4%) infant]. Seventy-four percent of infants in the atrial
shunt group and 90% of infants in the nonatrial shunt group
ceased oxygen supplementation 1 year after the initial
diagnosis of PH; however, these data were not statistically
significant (p Z 0.327).
Among the PH-BPD infants with interatrial shunts, 62%
(n Z 13) of infants were finally diagnosed as having ASDs
and 24% (n Z 5) of infants were diagnosed as having PFOs,
after a corrected postnatal age of 2 months. At the final
follow-up assessment, 67% of these defects (n Z 14) had
spontaneously closed, and 14% of the infants (n Z 3) un-
derwent a primary closure operation for ASD.4. Discussion
To our knowledge, this report is the first to directly inves-
tigate the association between atrial left-to-right shuntsand PH in premature infants with BPD. Mourani et al9
reviewed the medical charts of the children diagnosed
with CLD and who underwent cardiac catheterization for PH
evaluation. In particular, the authors reported that 68% of
the patients had a history of shunt lesions, primarily atrial
shunts, which were detected in 58% of this subgroup of
patients. The authors also noted the impact of left-to-right
shunt lesions in children with CLD and suggested early
treatment considerations for pulmonary overcirculation.
The incidence of atrial left-to-right shunt was 42% at 36
weeks PMA among the BPD-PH infants in our institution; and
67% of these defects spontaneously closed by the last
follow up. Three infants with left-to-right shunts through
moderate-sized ASDs underwent primary closure operations
with positive results. The size of each ASD at 36 weeks PMA
was 4 mm, 4.67 mm, and 5.5 mm. These infants showed
improved respiratory functions after the shunts were
closed. However, severe PH persisted, despite the admin-
istration of PH-specific drugs. We demonstrated that the
presence of a left-to-right shunt flow over the atrial septum
in moderate or severe BPD infants was associated with the
development of PH, compared to infants without atrial
shunt.
In general, patients with large and complex defects are
at the greatest risk for PH, compared to pre-tricuspid shunt
patients (i.e., ASD), who generally never develop PH.16,17
Atrial left-to-right shunts are frequently detected during
routine cardiac screening in BPD infants in NICUs,15 and the
high rate of spontaneous closure or decrease in the size of
the atrial defect in the first months of life is frequently
observed.18 For this reason, it is unusual to require closure
of an ASD in infants without an associated lung disease.19
However, poorer lung compliance in premature infants
could prevent or delay closure of the interatrial septum
because of greater phasic respiratory changes in intratho-
racic, left atrial, and right atrial pressures.20 If there are
persistent left-to-right cardiac shunts in BPD lungs, small
shunts can have a greater impact on pulmonary blood flow
322 E.K. Choi et aland aggravate PH because the lungs have an overall
reduction in alveolar-capillary surface area with vascular
remodeling.10,12 Furthermore, PH may be exaggerated by
vascular abnormalities such as pulmonary vein stenosis,
which often occurs in association with left-to-right cardiac
shunts.21,22 Based on the findings from our study and pre-
viously published reports describing success in closing ASDs
in patients with CLD,22e25 we suggest that early manage-
ment, which includes closure of the ASD, should be
considered as an optional treatment in infants with mod-
erate or large atrial shunt lesions who are unresponsive to
traditional PH therapies. Close follow up is needed to
evaluate the severity of PH using echocardiography, and
diuretics (which reduce pulmonary overflow) can be
considered to relieve acute respiratory symptoms. The
addition of biomarkers such as brain natriuretic peptide
levels would also be useful for serial follow ups. Cardiac
catheterization is needed for infants with a history of atrial
left-to-right shunts and persistent signs of severe cardio-
respiratory disease; it is important to select infants with
BPD who would benefit from closing the left-to-right
shunts.26 Early assessment and intervention of anatomic
cardiac lesions can decrease the incidence of adverse
outcomes such as heart failure.
In the current study, culture-proven sepsis was a specific
risk factor for PH in preterm infants with moderate or se-
vere BPD. Forty-six percent of preterm infants with PH had
a history of proven sepsis, which was significantly greater
than the number of infants that had moderate or severe
BPD without PH. This result closely aligns with those of
earlier studies that reported that infectious respiratory
illnesses were triggers for PH, particularly if the infant was
oxygen-dependent.13,27
Our study is limited by its retrospective design. The
time of diagnosis may not be accurate because the evalu-
ation interval was determined based on the infant’s con-
dition. Echocardiography is not the gold standard for
assessing pulmonary artery pressure. The assessment of
the atrial shunt was quantitative, and we did not have data
on the quality of the shunt lesions to assess the patient-
specific hemodynamics of each defect. Echocardiography
alone could not accurately determine the hemodynamic
impact of small atrial defects. A significant difference was
noted between the mortality rates of PH-BPD infants with
and without atrial left-to-right shunt; however, the small
sample size requires careful interpretation of the data to
assess this outcome; thus, additional larger studies are
needed.
In conclusion, this study confirms that preterm infants
with PH-BPD have higher rates of death and serious
morbidities, compared to infants without PH. We found
that preterm infants with a history of atrial left-to-right
shunts at 36 weeks PMA had an increased likelihood of
developing PH, compared to infants without any cardiac
shunts. Because of the high incidence of small atrial left-
to-right shunts in preterm infants, we propose a more
tailored prognostic evaluation of and diagnostic inter-
vention for BPD infants with cardiac shunt lesions. Addi-
tional prospective studies of the impact of cardiac shunt
lesions in infants with BPD are needed to determine the
risk factors for PH development in preterm infants with
BPD.Conflicts of interest
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